Clinical characteristics of IgA nephropathy associated with low complement 4 levels

References

• Simon P, Ramee MP, Boulahrouz R, et al. Epidemiologic data of primary glomerular diseases in western France. Kidney Int. 2004;66:905–908
   PubMed Web of Science ®Google Scholar
• Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies. Kidney Int. 2004;66:920–923
   PubMed Web of Science ®Google Scholar
• Coppo R, Amore A, Peruzzi L, Vergano L, Camilla R. Innate immunity and IgA nephropathy. J Nephrol. 2010;23:626–632
   PubMed Web of Science ®Google Scholar
• Soto K, Wu YL, Ortiz A, Aparicio SR, Yu CY. Familial C4B deficiency and immune complex glomerulonephritis. Clin Immunol. 2010;137:166–175
   PubMed Web of Science ®Google Scholar
• Bogers WM, Stad RK, van Es LA, Daha MR. Immunoglobulin A: Interaction with complement, phagocytic cells and endothelial cells. Complement Inflamm. 1991;8:347–358
   PubMedGoogle Scholar
• Wyatt RJ, Kanayama Y, Julian BA, et al. Complement activation in IgA nephropathy. Kidney Int. 1987;31:1019–1023
   PubMed Web of Science ®Google Scholar
• Rifai A, Chen A, Imai H. Complement activation in experimental IgA nephropathy: An antigen-mediated process. Kidney Int. 1987;32:838–844
   PubMed Web of Science ®Google Scholar
• Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR. Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol. 2001;167:2861–2868
   PubMed Web of Science ®Google Scholar
• Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. Nephrol Dial Transplant. 1998;13:1984–1990
   PubMed Web of Science ®Google Scholar
• Matsuda M, Shikata K, Wada J, et al. Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy. Nephron. 1998;80:408–413
   PubMed Web of Science ®Google Scholar
• Sjoholm AG. Inherited complement deficiency states: Implications for immunity and immunological disease. APMIS. 1990;98:861–874
   PubMed Web of Science ®Google Scholar
• Blanchong CA, Zhou B, Rupert KL, et al. Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease. J Exp Med. 2000;191:2183–2196
   PubMed Web of Science ®Google Scholar
• Truedsson L, Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus. Autoimmunity. 2007;40:560–566
   PubMed Web of Science ®Google Scholar
• Jin DK, Kohsaka T, Koo JW, Ha IS, Cheong HI, Choi Y. Complement 4 locus II gene deletion and DQA1*0301 gene: Genetic risk factors for IgA nephropathy and Henoch-Schönlein nephritis. Nephron. 1996;73:390–395
   PubMed Web of Science ®Google Scholar
• Wopenka U, Thysell H, Sjoholm AG, Truedsson L. C4 phenotypes in IgA nephropathy: Disease progression associated with C4A deficiency but not with C4 isotype concentrations. Clin Nephrol. 1996;45:141–145
   PubMed Web of Science ®Google Scholar
• Welch TR, Berry A, Beischel LS. C4 isotype deficiency in IgA nephropathy. Pediatr Nephrol. 1987;1:136–139
   PubMed Web of Science ®Google Scholar
• McLean RH, Wyatt RJ, Julian BA. Complement phenotypes in glomerulonephritis: Increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schönlein purpura. Kidney Int. 1984;26:855–860
   PubMed Web of Science ®Google Scholar
• Shen PC, He LQ, Tang Y, Wang Q, Wang W, Li J. Clinicopathological characteristics and prognostic factors of asymptomatic IgA nephropathy. J Investig Med. 2010;58:560–565
   PubMed Web of Science ®Google Scholar
• Shen P, He L, Li Y, Wang Y, Chan M. Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients. Nephron Clin Pract. 2007;106:c157–c161
   PubMed Web of Science ®Google Scholar
• Cheng J, Zhang X, Zhang W, He Q, Tao X, Chen J. Efficacy and safety of glucocorticoids therapy for IgA nephropathy: A meta-analysis of randomized controlled trials. Am J Nephrol. 2009;30:315–322
   PubMed Web of Science ®Google Scholar
• Kawasaki Y. The pathogenesis and treatment of IgA nephropathy. Fukushima J Med Sci. 2008;54:43–60
   PubMedGoogle Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470
   PubMed Web of Science ®Google Scholar
• Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–2944
   PubMed Web of Science ®Google Scholar
• Roberts IS, Cook HT, Troyanov S, et al. The Oxford classification of IgA nephropathy: Pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76:546–556
   PubMed Web of Science ®Google Scholar
• Cattran DC, Coppo R, Cook HT, et al. The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76:534–545
   PubMed Web of Science ®Google Scholar
• Lee SM, Rao VM, Franklin WA, et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol. 1982;13:314–322
   PubMed Web of Science ®Google Scholar
• Katafuchi R, Kiyoshi Y, Oh Y, et al. Glomerular score as a prognosticator in IgA nephropathy: Its usefulness and limitation. Clin Nephrol. 1998;49:1–8
   PubMed Web of Science ®Google Scholar
• Andreoli SP, Bergstein JM. Treatment of severe IgA nephropathy in children. Pediatr Nephrol. 1989;3:248–253
   PubMed Web of Science ®Google Scholar
• Wu F, Jiang XD, Xiu-Zhu Z. The measurement of C4 concentration for different genotype in Chinese patients. J Immunol. 1992;8:256–259
   Google Scholar
• Welch TR, Beischel L, Berry A, Forristal J, West CD. The effect of null C4 alleles on complement function. Clin Immunol Immunopathol. 1985;34:316–325
   PubMedGoogle Scholar
• Hauptmann G, Tappeiner G, Schifferli JA. Inherited deficiency of the fourth component of human complement. Immunodefic Rev. 1988;1:3–22
   PubMedGoogle Scholar
• Lin Q, Min Y, Li Y, et al. Henoch-Schönlein purpura with hypocomplementemia. Pediatr Nephrol. 2012;27:801–806
   PubMed Web of Science ®Google Scholar
• Roos A, Rastaldi MP, Calvaresi N, et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol. 2006;17:1724–1734
   PubMed Web of Science ®Google Scholar
• Kouki P, Marsh JE, Sacks SH, Sheerin NS. Autoimmune renal injury in C3- and C4-deficient mice: A histological and functional study. Nephron Exp Nephrol. 2004;96:e14–e22
   PubMedGoogle Scholar
• Foltz CJ, Cork LC, Winkelstein JA. Absence of glomerulonephritis in guinea pigs deficient in the fourth component of complement. Vet Pathol. 1994;31:201–206
   PubMed Web of Science ®Google Scholar
• Sheerin NS, Springall T, Carroll MC, Hartley B, Sacks SH. Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice. Clin Exp Immunol. 1997;110:403–409
   PubMed Web of Science ®Google Scholar
• Hebert MJ, Takano T, Papayianni A, et al. Acute nephrotoxic serum nephritis in complement knockout mice: Relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria. Nephrol Dial Transplant. 1998;13:2799–2803
   PubMed Web of Science ®Google Scholar
• Wyatt RJ, Julian BA, Woodford SY, et al. C4A deficiency and poor prognosis in patients with IgA nephropathy. Clin Nephrol. 1991;36:1–5
   PubMed Web of Science ®Google Scholar
• Circolo A. Binding of C4 by IgM. J Immunol. 1983;130:1012
   PubMedGoogle Scholar
• Gatenby PA, Barbosa JE, Lachmann PJ. Differences between C4A and C4B in the handling of immune complexes: The enhancement of CR1 binding is more important than the inhibition of immunoprecipitation. Clin Exp Immunol. 1990;79:158–163
   PubMed Web of Science ®Google Scholar
• Quigg RJ, Lim A, Haas M, Alexander JJ, He C, Carroll MC. Immune complex glomerulonephritis in C4- and C3-deficient mice. Kidney Int. 1998;53:320–330
   PubMed Web of Science ®Google Scholar
• Welch TR, McAdams J. Immunoglobulin M and C1q mesangial labeling in IgA nephropathy. Am J Kidney Dis. 1998;32:589–592
   PubMed Web of Science ®Google Scholar
• Abuelo JG, Esparza AR, Matarese RA, Endreny RG, Carvalho JS, Allegra SR. Crescentic IgA nephropathy. Medicine (Baltimore). 1984;63:396–406
   PubMed Web of Science ®Google Scholar
• Tang Z, Wu Y, Wang QW, et al. Idiopathic IgA nephropathy with diffuse crescent formation. Am J Nephrol. 2002;22:480–486
   PubMed Web of Science ®Google Scholar
• Mustonen JT, Rantala IS, Helin HJ, Pasternack AI. IgA-IgM nephropathy. A subgroup of primary mesangial glomerulonephritis. Am J Clin Pathol. 1991;95:863–866
   PubMed Web of Science ®Google Scholar
• Moriyama T, Shimizu A, Takei T, Uchida K, Honda K, Nitta K. Characteristics of immunoglobulin A nephropathy with mesangial immunoglobulin G and immunoglobulin M deposition. Nephrology (Carlton). 2010;15:747–754
   PubMed Web of Science ®Google Scholar
• Glassock RJ. The pathogenesis of IgA nephropathy. Curr Opin Nephrol Hypertens. 2011;20:153–160
   PubMed Web of Science ®Google Scholar
• Bishof NA, Welch TR, Beischel LS. C4B deficiency: A risk factor for bacteremia with encapsulated organisms. J Infect Dis. 1990;162:248–250
   PubMed Web of Science ®Google Scholar
• Jaatinen T, Ruuskanen O, Truedsson L, Lokki ML. Homozygous deletion of the CYP21A-TNXA-RP2-C4B gene region conferring C4B deficiency associated with recurrent respiratory infections. Hum Immunol. 1999;60:707–714
   PubMed Web of Science ®Google Scholar
• Kainulainen L, Peltola V, Seppänen M, et al. C4A deficiency in children and adolescents with recurrent respiratory infections. Hum Immunol. 2012;73:498–501
   PubMed Web of Science ®Google Scholar
• Seppanen M, Suvilehto J, Lokki ML, et al. Immunoglobulins and complement factor C4 in adult rhinosinusitis. Clin Exp Immunol. 2006;145:219–227
   PubMed Web of Science ®Google Scholar
• Yagame M, Tomino Y, Eguchi K, et al. Correlation between the pharyngeal secretion of IgA, secretory-IgA and free secretory component and the upper respiratory tract infections in patients with IgA nephropathy. Nihon Jinzo Gakkai Shi. 1987;29:1101–1105
   PubMedGoogle Scholar
• Tomino Y, Sakai H. Exacerbating factors in patients with IgA nephropathy. Semin Nephrol. 1987;7:315–317
   PubMed Web of Science ®Google Scholar
• Miura M, Tomino Y, Suga T, Endoh M, Nomoto Y, Sakai H. Increase in proteinuria and/or microhematuria following upper respiratory tract infections in patients with IgA nephropathy. Tokai J Exp Clin Med. 1984;9:139–145
   PubMedGoogle Scholar
• Ohsawa I, Ishii M, Ohi H, Tomino Y. Pathological scenario with the mannose-binding lectin in patients with IgA nephropathy. J Biomed Biotechnol. 2012;2012:476739
   PubMedGoogle Scholar